Church & Dwight Co., Inc. Revenue in 2024

Church & Dwight Co., Inc. reported $6.1B in revenue for fiscal year 2024. This represents a growth of 4.1% compared to the 2023 figure of $5.9B.

In FY2024, the U.S. Government refunded Church & Dwight $40.1 million related to a favorable tariff ruling on products imported from China. That single event — unrelated to operating performance — reduced cost of goods sold by $31.6 million and increased interest income by $4.8 million. Revenue for the year reached $6.107 billion, with net income of $585.3 million. Strip out the tariff benefit and the underlying numbers are still solid, but the comparison understates organic margin performance. The company's revenue has compounded steadily: $5.38 billion in 2022, $5.87 billion in 2023, $6.11 billion in 2024. That's not explosive growth. It's the kind of durable, mid-single-digit organic expansion that premium CPG brands generate when their category positions are entrenched and pricing power is intact. The $357.1 million vitamin brand impairment in Q3 2024 was the most significant negative event in the company's recent history. Private-label competition in the vitamin, mineral, and supplement category eroded the market share assumptions that justified the original acquisition premium. Management took the write-down cleanly rather than restructuring around it. Kirkland Signature and store-brand alternatives are the structural threat to every Church & Dwight brand that isn't Arm & Hammer or Trojan. Those two are category-defining in ways that resist private-label substitution. The eleven others have varying degrees of pricing power. Waterpik is defensible on patent grounds. OxiClean competes on performance claims. The vitamin brands — as Q3 2024 demonstrated — were not.